Homoeopathic Treatment Of Uterine Fibroid Using Epihysterinum

Phase 4

Not yet recruiting

• Conditions: Leiomyoma of uterus, unspecified,

• Registration Number: CTRI/2023/05/052233
• Lead Sponsor: RBTS GOVT HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

Brief Summary

Uterine fibroids are noncancerous growths of the uterus that oftenappear during childbearing years. Also called leiomyomas or myomas[1]. Symptoms of fibroid uterus- asymptomaticin majority (75%), menstrual abnormality: menorrhagia, metrorrhagiadysmenorrhea, dyspareunia, subfertility, pressure symptoms, recurrent pregnancyloss (miscarriage, preterm labor), lower abdominal or pelvic pain,abdominal enlargement. The increasing prevalence and risk of progression of the diseasehas increased the cases of secondary infertility, this demands therapeutic attention. With thisintention, we plan to test the effectiveness of Epihysterinum in uterine fibroid.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-05
• Last Update Posted: 2023-04-29

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 35

Inclusion Criteria

• Self reported and prediagnosed cases of Uterine Fibroids.
• Patients with symptomatology of Uterine Fibroids.
• Cases confirmed by USG or Laproscopy.
• Uterine fibroid of size less than 12 weeks.

Exclusion Criteria

• Patients or its guardian unwilling to take part or not giving consent to join the study.
• Diagnosed cases of systemic diseases psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure.
• Substance abuse and or dependence.
• Self reported immunecompromised state.
• Uterine Fibroid of size more than 12 weeks Persistent uterine bleeding despite medical therapy Excessive pain or pressure symptoms Recurrent pregnancy loss due to fibroid/or Rapidly growing myoma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in their symptomatology.	0-3 MONTHS
Improvement in Aberdeen Menorrhagia Severity Scale(AMSS) score.	0-3 MONTHS

Secondary Outcome Measures

Name	Time	Method
uterine fibroids Symptom and Quality of life UFSQOL	0-6 MONTHS

Trial Locations

Locations (1)

OPD 3 and IPD Dept of Obs and Gyn RBTS GOVT HOM MED COLLEGE AND HOSPITAL; 🇮🇳 Muzaffarpur, BIHAR, India

OPD 3 and IPD Dept of Obs and Gyn RBTS GOVT HOM MED COLLEGE AND HOSPITAL

🇮🇳Muzaffarpur, BIHAR, India

DR KAJAL

Principal investigator

7979096206

kajalrbts04@gmail.com